Regulus Therap (RGLS) Posts Mixed Q2 Results
Regulus Therap (NASDAQ: RGLS) reported Q2 EPS of ($0.20), $0.06 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
